Massive transfusion

Journal of the Royal Army Medical Corps

Volumn 157, Issue 3 SUPP. 1, 2011, Pages

  Doughty, H A ^a   Woolley, T ^b   Thomas, G O R ^c  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

^c QUEEN VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; HEMORRHAGIC SHOCK; HEMOSTASIS; HUMAN; INJURY; METHODOLOGY; MONITORING; THROMBOCYTE TRANSFUSION; WAR;

AFGHAN CAMPAIGN 2001-; BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; HEMOSTASIS; HUMANS; MONITORING, PHYSIOLOGIC; PLATELET TRANSFUSION; SHOCK, HEMORRHAGIC; WOUNDS AND INJURIES;

EID: 84856399002     PISSN: 00358665     EISSN: None     Source Type: Journal    
DOI: 10.1136/jramc-157-03s-04     Document Type: Article

References (47)

1. SGD. Management of Massive Haemorrhage on Operations. SGPL. 2009 Jun 10:1-21.
2. Kirkman E, Watts S, Hodgetts T et al. A proactive approach to the coagulopathy of trauma: the rationale and guidelines for treatment. J R Army Med Corps 2008;153(4):302-6.
3. Blood Safety and Quality Regulations 2005. Statutory Instrument 2005/50, (2005).
4. Malone DL, Hess JR, Fingerhut A. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. J Trauma 2006;60(6 Suppl):S91-6.
5. Borgman MA, Spinella PC, Perkins JG et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007;63(4):805-13.
6. Allcock E, Woolley T, Midwinter M, Mahoney P, Mackenzie I. The clinical outcome of uk military personnel who received a massive transfusion in Afghanistan during 2009. J R Army Med Corps in press.
7. Feliciano D, Mattox K, Jordan GJ. Intra-abdominal packing for control of hepatic hemorrhage: a reappraisal. J Trauma 1981;21(4):285.
8. Allen SR, Kashuk JL. Unanswered questions in the use of blood component therapy in trauma. Scand J Trauma Resusc Emerg Med 2011;19:5.
9. Brohi K, Cohen MJ, Ganter MT et al. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 2007;245(5):812-8.
10. Ganter MT, Cohen MJ, Brohi K et al. Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma? Ann Surg 2008;247(2):320.
11. Brohi K, Singh J, Heron M, Coats T. Acute Traumatic Coagulopathy. J Trauma 2003;54(6):1127-30.
12. McMullin N, Holcombe J, Sondeen J. Yearbook of Intensive Care and Emergency Medicine. In: Vincent J, editor. New York: Springer; 2006. p. 265-78.
13. Gunter OL, Au BK, Isbell JM et al. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma 2008;65(3):527-34.
14. Duchesne JC, Hunt JP, Wahl G et al. Review of current blood transfusions strategies in a mature level I trauma center: were we wrong for the last 60 years? J Trauma 2008;65(2):272-6.
15. Sperry JL, Ochoa JB, Gunn SR et al. An FFP: PRBC transfusion ratio>= 1: 1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma 2008;65(5):986.
16. Moor P, Rew D, Midwinter M, Doughty H. Transfusion for trauma: civilian lessons from the battlefield? Anaesthesia 2009;64(5):469-72.
17. Davenport R, Curry N, Manson J et al. Hemostatic effects of fresh frozen plasma may be maximal at red cell ratios of 1: 2. J Trauma 2011;70(1):90.
18. Aboudara MC, Hurst FP, Abbott KC, Perkins RM. Hyperkalemia after packed red blood cell transfusion in trauma patients. J Trauma 2008;64(2):S86.
19. Hoffman M. The cellular basis of traumatic bleeding. Mil Med 2004;169(12 Suppl):5.
20. Lier H, Krep H, Schroeder S, Stuber F. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma 2008;65(4):951-60.
21. Hästbacka J, Pettilä V. Prevalence and predictive value of ionized hypocalcemia among critically ill patients. Acta Anaesthesiol Scand 2003;47(10):1264-9.
22. Spahn DR. Hypocalcemia in trauma: Frequent but frequently undetected and underestimated. Crit Care Med 2005;33(9):2124.
23. Fukuda T, Nakashima Y, Harada M et al. Effect of whole blood clotting time in rats with ionized hypocalcemia induced by rapid intravenous citrate infusion. J Toxicol Sci 2006;31(3):229-34.
24. Brass LF. More pieces of the platelet activation puzzle slide into place. J Clin Invest 1999;104(12):1663-6.
25. Spoerke NJ, Van PY, Differding JA et al. Red blood cells accelerate the onset of clot formation in polytrauma and hemorrhagic shock. J Trauma 2010;69(5):1054-9; discussion 9-61.
26. Counts R, Haisch C, Simon T et al. Hemostasis in massively transfused trauma patients. Ann Surg 1979;190(1):91.
27. Martini WZ, Cortez DS, Dubick MA, Park MS, Holcomb JB. Thrombelastography is better than PT, aPTT, and Activated Clotting Time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs. J Trauma 2008;65(3):535-43.
28. Hoffman M, Monroe DM. A cell-based model of hemostasis. Thromb Haemost 2001;85(6):958-65.
29. Doran CM, Woolley T, Midwinter MJ. Feasibility of using rotational thromboelastometry to assess coagulation status of combat casualties in a deployed setting. J Trauma 2010;69 Suppl 1:S40-8.
30. Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009;17:45.
31. Schöchl H, Nienaber U, Hofer G et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010;14(2):R55.
32. Theusinger OM, Spahn DR, Ganter MT. Transfusion in trauma: why and how should we change our current practice? Curr Opin Anaesthesiol 2009;22(2):305-12.
33. Woolley T, Spencer P, Doran C, Watts S, Kirkman E. Utility of interim ROTEM values to predict hypocoagulability. Brit J Surg 2010;97(S2): 1-75 (Abstract)
34. Martinowitz U, Michaelson M. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force. J Thromb Haemost 2005;3(4):640-8.
35. Stein DM, Dutton RP, O'Connor J, Alexander M, Scalea TM. Determinants of futility of administration of recombinant factor VIIa in trauma. J Trauma 2005;59(3):609-15.
36. Thomas GOR, Dutton RP, Hemlock B et al. Thromboembolic complications associated with factor VIIa administration. J Trauma 2007;62(3):564.
37. Boffard KD, Riou B, Warren B et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, doubleblind clinical trials. J Trauma 2005 59(1):8-15
38. Lin Y, Stanworth S, Birchall J, Doree C, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2007.
39. Rossaint R, Bouillon B, Cerny V et al. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010;14(2):R52.
40. Henry D, Carless P, Moxey A et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion (Review). Cochrane Database Syst Rev 2001.
41. The CRASH2 Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hamorrhage (CRASH2): a randomised, placebocontrolled trial. Lancet 2011;376:23-32.
42. Dawes R, Thomas G. Battlefield resuscitation. Curr Opin Crit Care 2009;15(6):527.
43. Koch CG, Li L, Sessler DI et al. Duration of red-cell storage and complications after cardiac surgery. New Engl J Med 2008;358(12):1229-39.
44. Fontaine MJ, Chung YT, Erhun F, Goodnough LT. Age of blood as a limitation for transfusion: potential impact on blood inventory and availability. Transfusion 2010; 50(10):2233-9.
45. Shuja F, Shults C, Duggan M et al. Development and testing of freeze-dried plasma for the treatment of trauma-associated coagulopathy. J Trauma 2008;65(5):975.
46. Sørensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol 2010;149(6):834-43.
47. Spinella PC, Perkins JG, Grathwohl KW et al. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital. Crit Care Med 2007;35(11):25761